dc.creatorDe Giusti, Verónica Celeste
dc.creatorCaldiz, Claudia Irma
dc.creatorEnnis, Irene Lucía
dc.creatorPérez, Néstor Gustavo
dc.creatorCingolani, Horacio Eugenio
dc.creatorAiello, Ernesto Alejandro
dc.date2013
dc.date2019-11-13T13:41:59Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/85467
dc.identifierissn:1664-042X
dc.descriptionMitochondria represent major sources of basal reactive oxygen species (ROS) production of the cardiomyocyte. The role of ROS as signaling molecules that mediate different intracellular pathways has gained increasing interest among physiologists in the last years. In our lab, we have been studying the participation of mitochondrial ROS in the intracellular pathways triggered by the renin-angiotensin II-aldosterone system (RAAS) in the myocardium during the past few years. We have demonstrated that acute activation of cardiac RAAS induces mitochondrial ATP-dependent potassium channel (mitoK<SUB>ATP</SUB>) opening with the consequent enhanced production of mitochondrial ROS. These oxidant molecules, in turn, activate membrane transporters, as sodium/hydrogen exchanger (NHE-1) and sodium/bicarbonate cotransporter (NBC) via the stimulation of the ROS-sensitive MAPK cascade. The stimulation of such effectors leads to an increase in cardiac contractility. In addition, it is feasible to suggest that a sustained enhanced production of mitochondrial ROS induced by chronic cardiac RAAS, and hence, chronic NHE-1 and NBC stimulation, would also result in the development of cardiac hypertrophy.
dc.descriptionFacultad de Ciencias Médicas
dc.descriptionCentro de Investigaciones Cardiovasculares
dc.formatapplication/pdf
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by/3.0/
dc.rightsCreative Commons Attribution 3.0 Unported (CC BY 3.0)
dc.subjectCiencias Médicas
dc.subjectCardiac myocyte
dc.subjectReactive oxygen species
dc.subjectSecond messenger systems
dc.subjectSodium-bicarbonate symporters
dc.subjectSodium-hydrogen antiporter
dc.titleMitochondrial reactive oxygen species (ROS) as signaling molecules of intracellular pathways triggered by the cardiac renin-angiotensin II-aldosterone system (RAAS)
dc.typeArticulo
dc.typeRevision


Este ítem pertenece a la siguiente institución